Degenerative disc disease (DDD) is a common disease which affects millions of people. Autograft of the bone marrow derived mesenchymal stem cells (BMSCs) have been shown to have the ability to arrest degeneration in rabbit and canine intervertebral discs. In this study, we have used the mouse model to investigate the mechanism of degeneration arrest. BMSC from Egfp transgenic mice were injected into the degenerated murine intervertebral discs induced by annular puncture. We found that BMSC could arrest the progressive degeneration of the discs with significant regeneration of the nucleus pulposus (NP). In the regeneration, expression of proteoglycan genes were upregulated and extracellular matrix (ECM) progressively accumulated in the NP after BMSC injection. Combined in situ hybridization and immunohistochemistry revealed that BMSC underwent chondrocytic differentiation in the regeneration process. Interestingly, BMSC-induced an increase of endogenous notochordal cells in NP and expression of chondrocytic markers. In this study, we have firstly shown that the BMSC could arrest the degeneration of the murine notochordal NP and contribute to the augmentation of the ECM in the NP by both autonomous differentiation and stimulatory action on endogenous cells.
IntroductIon
Degenerative disc disease (DDD) is a common disease which is a major cause of the pain-related disabilities. Pain-related costs aggravate the economic burden of the whole industrial society. 1 Compared with the normal disc, the degenerated disc has morphological changes such as the irregular lamellas in the annulus fibrosus (AF) and the diminished celluarity in the nucleus pulposus (NP). There are also biochemical changes in the degenerated disc, including loss of hydration and decrease of osmotic pressure, quantitative and distributive changes of collagen, decreased proteoglycan content and downregulated proteoglycan expression. 2 Various kinds of biological therapeutic methods have been studied in the hope of regenerating the dysfunctional discs for DDD. 3 Among these methods increasing the number of functional cells in NP can be a key to improve the function of intervertebral discs. 4 Previous studies have suggested that bone marrow derived mesenchymal stem cells (BMSCs) could differentiate toward a NP-like phenotype in vitro. 5 Coculture of human BMSC and NP cells may also induce BMSC to differentiate and express NP-like markers. 6, 7 Mochida et al. have studied the regenerative effect of autologous BMSC on disc degeneration and demonstrated BMSC may induce recovery of disc height and proteoglcyan level in both rabbit and canine model. [8] [9] [10] [11] The injected BMSC could survive up to 48 weeks in the rabbit disc 12 and express some markers like hypoxia-inducible factor 1 and keratin sulfate, 12 suggesting the differentiation of BMSC in the discs.
Compared with human and other large animals mouse has more notochordal cellular components in the NP. Notochordal cells have been suggested to play an important role in regulating the metabolism of the NP 13 and the loss of the notochordal cells in NP is closely related to the onset of the disc degeneration. 13 Although previous studies showed that BMSC implantation can be a strategy to treat disc degeneration; whether BMSC could stimulate the notochordal NP in vivo and the differentiation status of BMSC in the regeneration process are not very clear. Studying disc degeneration in mouse model would therefore provide a valuable opportunity to study the differentiation of stem cells in notochordal NP and explore the possible roles of notochordal cells in the regeneration process.
In order to test the hypothesis that BMSC could arrest the degeneration of notochordal NP, we established a mouse injured disc model 14 to investigate the effects of BMSC and mechanism of degeneration arrest. We found that BMSC could arrest the progressive degeneration of the notochordal NP and the effect was associated with the re-establishment of type II collagen and proteoglycans-enriched extracellular matrix (ECM) in the NP. Differentiation of BMSC into a chondrocytic phenotype and an increased number of Col2a1-expressing endogenous cells in the NP might have contributed to the re-established ECM. Our study has provided new insights into how BMSC behave and contribute to the regenerative process in notochordal NP and hence ways to improve stem cell therapy for DDD in future.
results
Progressive degeneration of the intervertebral disc induced by the annulus puncture Safranin O staining was performed to follow the progressive degenerative changes of the disc structure and glycosaminoglycan (GAG) distributive pattern after the puncture. The original notochordal phenotype of the murine discs gradually changed from pre-op to 12 weeks (Figure 1a-d) . In the pre-op disc the lamellas in AF are parallel and NP contained many vacuolated notochordal cells (Figure 1a) . At 2 weeks after the puncture the annulus became infolded and disorganized with safranin O-positive matrix concentrated in the NP (Figure 1b) . At 6 weeks, clusters of small unvacuolated cells were observed in the NP (Figure 1c) ; Finally, at 12 weeks after the puncture the boundary between the AF and NP disappeared and GAG distribution became diffused in the disc, although some clefts could be observed in both AF and NP region (Figure 1d) .
A degeneration grading system modified from the rabbits ( Supplementary Table S1 ), ranging the score from 0 to 8 was used to reflect the degree of degeneration after the puncture. The mean histological scores of punctured disc increased from pre-op to 2 weeks (P < 0.05), then increased significantly from 2 weeks to 12 weeks (P < 0.05) (Figure 1e) . Disc height index (DHI) decreased significantly at 2 and 6 weeks after the puncture compared with the normal control (P < 0.05). From 6 to 12 weeks, the DHI decreased further and was significantly lower than that of normal control (P < 0.01) (Figure 1f) .
Expression analysis of major proteoglycans and related genes showed that the expression of Col2a1, Aggrecan, and Sox9 were all downregulated continuously from 2 to 12 weeks compared with the pre-op control group (P < 0.05) (Figure 1g ). GAG and DNA contents were also quantified to reflect proteoglycan content changes (Figure 1h) . GAG/DNA decreased significantly at 6 week (P < 0.05) and 12 week (P < 0.05) compared with the pre-op control group.
Morphology and characterization of BMsc in vitro culture
BMSCs were isolated from the bone marrow of green fluorescent protein (GFP) mice. 15 The freshly harvested bone marrow derived cells have varied sizes and heterogeneous level of green fluorescence (data not shown); After the first passage the cells grew into Figure 1 Annulus puncture could induce the progressive degeneration of murine intervertebral disc. (a-d) Safranin O staining of the intervertebral discs from pre-op to 12 weeks after the puncture. Progressive degenerative changes were observed at (a) pre-op, (b) 2 weeks, (c) 6 weeks, and (d) 12 weeks after the puncture. Bar = 200 µm (e) the histological score increased from pre-op to 2 weeks (P < 0.05), then increased from 2 to 12 weeks (P < 0.05) after the puncture. (f) Disc height index (%DHI) decreased continuously at 2, 6 weeks (P < 0.05) and 12 weeks (P < 0.01) after the puncture. (g) The expression of Col2a1, Aggrecan, and Sox9 were significantly downregulated from pre-op to 12 weeks after the puncture (P < 0.01).
(h) Continuous decrease of GAG/DNA from pre-op to 12 weeks after the puncture. The GAG content decreased significantly at 6 and 12 weeks were compared with the pre-op control group (P < 0.05).GAG, glycosaminoglycan.
confluence and GFP signal intensity appeared more uniform among the cells (Figure 2a,b) . Immunostaining was performed to characterize the surface markers of the cultured BMSC. Most of the cultured BMSC expressed the standard mesenchymal stem cell surface markers 16 Stro-1 (Figure 2c) , and CD73 (Figure 2d ), whereas they did not express the hematopoietic markers CD34 (Figure 2e ) and CD45 (Figure 2f) . Gene expression analysis further showed that articular chondrocytes expressed two chondrocytic markers: Sox9 and Col2a1, which BMSC could not or expressed at very low level (Figure 2g ).
BMsc could arrest the progressive degeneration of the intervertebral discs BMSC was injected into the intervertebral discs 2 weeks after the degeneration was induced by annular puncture (Figure 2h) . In normal group, histology revealed that the AF composed of regularly aligned lamellas and NP appeared as an organized structure containing abundant cellular components (Figure 3a-c) . In degeneration group, the lamellas in AF became irregular and NP became disorganized and decreased in cellularity with clusters of cells formed at 4 weeks (Figure 3e) . At 24 weeks, the cellularity diminished further in NP and the extent of safranin O staining significantly reduced (Figure 3f ). In the treatment group such progressive degenerative changes were arrested. The alignment of lamellas in AF remained regular and parallel and the cellular components in NP were still abundant at 4 weeks postinjection (Figure 3h) . At 24 weeks, the structure of AF was still relatively intact; NP became dominantly positive for safranin O with increased matrix to cell ratio (Figure 3i) .
DHI remained relatively stable in normal group whereas decreased continuously in degeneration group from 0 to 24 weeks postinjection. The DHI of treatment group is significantly higher than degeneration group at 24 weeks (P < 0.05) (Figure 3j ). Histological grading (Figure 3k ) showed that at 4 weeks postinjection the mean score of treatment group (2.2) was significantly lower than degeneration group (P < 0.05). At 24 weeks postinjection the mean score of treatment group (3.8) was significantly lower than the degeneration group (P < 0.05), reflecting the degenerative process was arrested in the treatment group. From 4 to 24 weeks there is no significant change of histological score in the treatment group (P > 0.05).
ECM gene expression was upregulated in the discs after BMsc injection
Reverse transcription-PCR analysis showed that there is a decrease in the expression of Col2a1, Aggrecan, and Sox9 in the degeneration group whereas the reduction of expression was significantly arrested (P < 0.05) in treatment group at 24 weeks postinjection (Figure 4a) . GAG/DNA content in the treatment group was significantly higher compared with the degeneration group (P < 0.01) at 24 weeks postinjection (Figure 4b) .
In situ hybridization with Col2a1 probe showed that in normal group, Col2a1-expressing cells were concentrated in the inner annulus (AF) and the endplate (Figure 4c-e) . In degeneration . Immunostaining showed that in normal group, type II collagen was distributed regularly at the peripheral region of NP from 4 to 24 weeks (Figure 4l,m) . In degeneration group, little collagen II signal was detected in NP except trace signals around the cleft at 24 weeks (Figure 4o) . In treatment group, accumulation of collagen II was observed in the NP from 4 to 24 weeks (Figure 4p,q) .
chondrogenic differentiation of the BMsc in the disc GFP immunostaining showed a decreased number of BMSC by 24 weeks after the injection (Figure 5a) . At 4 weeks, most of the BMSC were spindle shape (Figure 5b,d arrow) . At 24 weeks postinjection, some BMSC attained a round chondrocyte-like morphology (Figure 5c ,e arrow). Co-staining GFP and chondrocytic markers (Sox9/Col2a1) revealed that some GFP-positive BMSC cells expressed Col2a1 (Figure 5f ) or Sox9 (Figure 5g ) at 4 weeks postinjection. The percentage of Col2a1 and Sox9 positive cells in NP was quantified to follow the differentiation status of BMSC after injection (Figure 5h) . We found that the number of Col2a1 + /GFP + cells increased from 4 weeks (42.5 ± 5.26%) to 24 weeks (61.92 ± 6.33%) postinjection (P < 0.05). Similarly, the number of Sox9 + /GFP + cells also increased significantly (47.6 ± 5.30% to 67.0 ± 5.41%, P < 0.05). This suggests a progressive chondrogenic differentiation of BMSC in NP after injection.
Increased population and expression of chondrocytic markers of endogenous cells after BMsc injection
The double-staining experiments also allowed us to trace and examine the GFP-negative endogenous notochordal cells. At 4 weeks postinjection the cell clusters formed in NP of treatment group comprised mostly endogenous vacuolated cells (Figure 6b , arrow) and was relatively more abundant than the degeneration group (Figure 6a, arrow) . At 24 weeks, the amount of endogenous cell clusters in treatment group (Figure 6d, arrow) was still more abundant than the degeneration group (Figure 6c, arrow) . By quantification, the number of GFP-negative endogenous cells in treatment group was significantly higher than degeneration group at both 4 weeks (P < 0.01) and 24 weeks (P < 0.05) (Figure 6e) . Double staining with Col2a1 probe and GFP antibody revealed four types of cells located in NP in treatment group: Col2a1 positive (Figure 6f ) and negative (Figure 6g) endogenous cells, as well In treatment group, the number of Col2a1 + /GFP − cells, which indicate the Col2a1-expressing endogenous cells, was significantly higher than the degeneration group at both 4 weeks (P < 0.05) and 24 weeks (P < 0.01) (Figure 6j) , suggesting that the endogenous cells in notochordal NP transformed into a chondrocytelike phenotype under the influence of BMSC.
dIscussIon
In this study we used an injured mouse tail disc model 14 to explore the effect and role of BMSC in the degenerative murine discs. By tracking the fate of both GFP-tagged BMSC and endogenous cells in NP, we firstly showed that a proportion of BMSC could survive up to 24 weeks in the degenerated murine intervertebral discs and arrest the progressive degeneration of the notochordal NP through self-differentiation and stimulatory effect on endogenous notochordal cells.
The survival rate of the allogenic cells is much dependent on the immune reactions. 17 In our study, we did not find infiltrating cells like neutrophils and lymphocytes after BMSC injection. This is in line with the notion that the intervertebral disc is being immune privileged owing to its avascular nature. 18 The decreased number of BMSC observed at 24 weeks postinjection suggests that the degenerative environment may be detrimental to the survival of the BMSC. We postulate that an alteration of nutrient diffusion in degenerated NP could be a potential factor that limit the activity and survival of BMSC in long term. 18 Our data showed that BMSC is beneficial in arresting the degenerative process of murine disc as the loss of disc height can be arrested from 4 to 24 weeks after BMSC injection. Histological assessment confirmed that the BMSC had regenerated the structure of the degenerated intervertebral disc, as indicated by reparation of both lamella organization in AF and partial recovery of cellular components in NP. The regenerative effect is also supported by the lowered degeneration grade observed in the BMSC treatment group.
The upregulated Aggrecan expression and the increased GAG content in the BMSC-treated discs suggested that the anabolic function of the intervertebral discs had been partially restored after the injection of BMSC. Increase of ECM composing collagen II from 4 to 24 weeks suggests the NP of the BMSC-treated discs has become cartilagenous from 4 to 24 weeks. The continuous accumulation of the ECM in NP could also explain the structural modulation and the disc height recovery of the BMSCtreated discs. The coexpression of GFP and Col2a1/Sox9 suggested chondrogenic differentiation of the BMSC in the notochordal NP. The increase of Col2a1 and Sox9 positive cells in the regeneration process from 4 to 24 weeks indicates that the chondrogenic differentiation of BMSC in NP is in parallel with the accumulation of cartilagenous matrix after BMSC injection. We postulate that the differentiated BMSC might have a role in contributing to the elevated Aggrecan expression and GAG content in NP which lead to the formation of Safranin O-positive matrix.
Then we investigated the in vivo interaction between BMSC and endogenous notochordal cells. Our data have demonstrated that BMSC have a stimulatory effect on the endogenous notochordal cells. BMSC injection induced an increase in the endogenous cell population in vivo, suggesting that BMSC can promote notochordal cell survival and proliferation, or prevent them from apoptosis. The BMSC could also stimulate the endogenous cells in notochordal NP to transform to chondrocytic phenotype through expressing chondrocytic markers, contributing to the deposition of cartilagenous ECM in NP. Previous studies have suggested that notochordal cells could maintain the metabolic balance of NP through signaling to surrounding cells 19 or stimulate cells in NP to synthesize ECM composed of proteoglycan. 20 Here our data further suggested that the anabolic function of notochordal cells could be stimulated by BMSC, thus contributing to the functional recovery of the NP. Endogenous cells played an important role in assisting the BMSC-based regeneration of the notochordal NP and maintaining the normal function of the intervertebral disc.
The balance of synthesis and degradation of the ECM determines the functional status of the intervertebral discs. Stem cells have been reported to regenerate the tissues and organs through multiple mechanisms. 21 In our study we hypothesize that two mechanisms co-exist in the BMSC-induced arrest of degeneration. On one hand, BMSC could directly differentiate into chondrocytic phenotype in the regeneration process possibly due to local niche in the NP; on the other hand, BMSC could also stimulate the endogenous notochordal cells or NP progenitors to proliferate or prevent them from undergoing apoptosis through secreting signaling molecules or direct cell-cell contact. 22 These stimulated endogenous cells, together with the differentiated BMSC, secreted cartilagenous ECM which outbalance the ECM degradation in NP and maintained the structure of the intervertebral disc.
Future investigation using transgenic mouse models may help further understanding the mechanism underlying the BMSCbased IVD regeneration, such as the mode of BMSC action and the origin of the de novo NP cells being induced. In addition, in order to correlate the increased GAG and ECM production in NP with the functional recovery of the intervertebral disc, the biomechanical property of the disc also needs to be investigated in future. As notochordal cells no longer exist in human degenerative disc, the clinical relevance or translation of the current study might be limited due to the presence of residue notochordal cells in the injured murine discs. Nevertheless, our findings indicate a role of notochordal cells in the stem cell-based regeneration process and hence provide insights in the design of new regenerative methods, such as cotransplantation of the notochordal cells and mesenchymal stem cell, for the treatment of DDD.
In conclusion, we have shown that allogenic BMSC can be viable in the degenerated murine intervertebral discs and arrest the degeneration through partial regeneration of the disc structure. BMSC can undergo chondrogenic differentiation and simultaneously stimulate the endogenous NP cells, either the notochordal cells or other progenitor cells, to re-establish a cartilaginous NP. Further understanding the molecular mechanisms of the regeneration, as well as tests in larger animal models shall substantiate the use of bone marrow derived stem cells in treating DDD in future.
MAterIAls And Methods
Establishment of injured mouse disc model by annular puncture. All experimental protocols were approved by the Committee on the Use of Live Animals in Teaching and Research of the University of Hong Kong. A total of 108 mice were used for the study. 45 C57 mice aged 10 weeks were used for the characterization of the degeneration process after the annular puncture. The other 63 mice were evenly divided into three groups: control normal group, degeneration group, and treatment group. Disc degeneration was induced in the tail discs in degeneration and treatment groups at caudal 4-5 level by annular puncture. Briefly, we anesthetized the mice by intraperitoneal injection of Hypnorm (0.5 ml/kg) and dormicum (0.5 ml/ kg; Janssen, Oxford, UK). 23 After locating the operative disc from radiographs, the target disc was punctured through the annulus by a 31G needle at a controlled depth of needle bevel under microscopic guidance. After the operation no leakage of disc tissue was found around the wound, then the subcutaneous muscle and skin were sutured and the mice were allowed of free activity in the cages.
BMSC culture and delivery into degenerated discs. Five GFP transgenic mice 15 aged 10 weeks were used for isolation of BMSC using the protocol adapted by Makino et al. 24 The purified cells were plated in the 75 cm 2 flask and cultured with Dulbecco's modified Eagle medium supplemented with 20% fetal calf serum and penicillin (100 U/ml)/streptomycin (100 μg/ ml). The culture medium was refreshed every 3 days and the nonadherent hematopoietic stem cells and other blood cells were removed after the second change of the medium. When the adherent cells became confluent, they were passaged and expanded. The articular chondrocytes were also isolated from the articular cartilage of the GFP mice as previous described. 25 Immunostaining and reverse transcription-PCR analysis were conducted for characterizing the surface markers and gene expression profile of the cultured BMSC.
At 2 weeks after the annular puncture, ~1 × 10 3 P1 BMSC in Dulbecco's modified Eagle medium (10 6 cells/ml in 1µl) were injected into the discs in the treatment group with a 33G micro-injector (Hamilton, Reno, NV); Only Dulbecco's modified Eagle medium was injected into the discs in degeneration group. After the operation the subcutaneous muscle and skin were sutured and the mice were allowed of free activity in the cages.
Radiographic analysis of disc height. Anterior-posterior radiographs of the mouse tail were taken at pre-op, 4 weeks and 24 weeks after BMSC injection using cabinet X-ray system (model 43855a; Faxitron, IL) with an exposure time of 40 second and penetration power of 20 kv. The DHI of the disc was calculated as previously described. 26 The change of the DHI was expressed as %DHI (post-op DHI/pre-op DHI). Two examiners participated in the image analysis for the DHI assessment. The inter observer error and the within-subject standard deviation were calculated.
Histological staining and grading. The discs and adjacent vertebral bodies were isolated at pre-op, 4 week and 24 weeks after BMSC injection. Tissue processing and sectioning was carried out as previously described. 27 Tissue sections were stained with safranin O for glycosaminogycan. A modified grading system (Supplementary Table S1 ) was used to assess the degree of degeneration based on the established rabbit disc grading system. 28 A grade score ranged from 1 to 4 was assigned to both AF and NP structure of the disc which were summated to obtain an overall score to determine the degree of degeneration.
Immunostaining. For detecting the surface markers of the GFP-expressing BMSC, BMSC at passage 1 was fixed with paraformaldehyde, then the mouse antibodies to Stro-1, CD73, CD34, CD45 (Invitrogen, Carlsbad, CA) at 5 μg/ml were used to characterize the surface markers of BMSC. For the tissues, the midsagittal sections of the discs were dewaxed, rehydrated, and blocked by goat serum. Then the sections were incubated with rabbit anti-GFP polyclonal antibody at 5 μg/ml, rabbit antimouse collagen II antibody or rabbit antimouse Sox9 antibody (Chemicon, Temecula, CA) at 10 μg/ml for 60 minutes. The slides containing cells or tissue sections were washed three times and then incubated with biotinylated secondary antimouse or antirabbit antibody (Vector, Burlingame, CA) for 30 minutes. The sections were washed again and treated with avidin-biotin complex reagents followed by 3, 3-diaminobenzendine reagents (Vector, Burlingame, CA). Sections were counterstained with Harris hematoxylin.
In situ hybridization. In situ hybridization using Col2a1 probe was performed on disc sections as previously described. 29 Briefly, the sections were hybridized with hybridization solution containing digoxygenin-UTPlabeled antisense riboprobes at 60 °C overnight. The sections were then treated with fluorescin-conjugated anti-digoxigenin antibody and color was developed. For double staining, immunostaining was performed after the in situ hybridization. Finally, the sections were counterstained with 4′,6-diamidino-2-phenylindole to stain the nuclei and then mounted. Gene expression analysis using reverse transcription-PCR. Total RNA were separately extracted from three whole intervertebral discs ( including endplates) isolated from each of the normal, degeneration and treatment groups at 24 weeks using Trizol method. RNA was also extracted from cultured BMSC and articular chondrocytes. Primers were chosen from the gene database (Supplementary Table S2) . PCR was performed by denaturation at 94 °C for 30 seconds, annealing at 55 °C for 30 seconds and extension at 68 °C for 45 seconds for a total of 35 cycles. The gels were scanned under UV light with a densitograph system (Chinetek Scientific, Hong Kong, P.R.China). The band density was semiquantified and normalized to Gapdh gene using the Image J software (version, 1.36, National Institutes of Health, Bethesda, MD).
Biochemical analysis. Three whole discs were isolated from each of the normal, degeneration, and treatment groups at 24 weeks after BMSC injection, then the disc tissues were digested overnight at 55 °C in 500 µl papain solution (200 μg/ml papain, 50 mmol/l EDTA, 5 mmol/l cystein). GAG content was analyzed by using microplate reader (SPECTRA MAX 340, Molecular Devices, Sunnyvale, CA) as previously described. 12 The DNA content of the discs was measured using Hoechst 33258 method. 12 The data was expressed as micrograms of GAG per micrograms of DNA (GAG/DNA).
Statistical analysis. The significance of differences among the means on radiograph measurement and number of GFP or Col2a1/Sox9 positive cells in different groups was tested by analysis of variance and Bonferroni's multiple comparison test was used as a post hoc test. The gene expression level and GAG/DNA level among different groups was tested by one way analysis of variance and Dunnett's multiple comparison test was used as a post hoc test. Mann-Whitney test was used to analyze the histological grading scores at different time points. All the statistical tests were performed using the Statview (version 5.0, SPSS, Chicago, IL) program package. A P value <0.05 was determined as statistical significance. Table S1 . Definition of the histological grading scale. Table S2 . Primers used for RT-PCR analysis.
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